Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

Blood (2012) 120 (21): 743.

https://doi.org/10.1182/blood.V120.21.743.743

Published: 2012

Journal Articles

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Martino Introna, MD, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Alice Pievani, PhD, Gianmaria Borleri, Josée Golay, PhD, Irene Cavattoni, MD, Sergio Cortelazzo, MD, Alessandro Rambaldi

Blood (2011) 118 (21): 657.

https://doi.org/10.1182/blood.V118.21.657.657

Published: 2011

Journal Articles

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

Erica Dander, PhD, Giovanna Lucchini, MD, Paola Vinci, Martino Introna, MD, Sonia Bonanomi, MD, Adriana Balduzzi, MD, Giuseppe Gaipa, PhD, Paolo Perseghin, MD, Francesca Masciocchi, Chiara Capelli, PhD, Josée Golay, PhD, Alessandra Algarotti, MD, Alessandro Rambaldi, MD, Attilio Rovelli, MD, Andrea Biondi, MD, Ettore Biagi, MD, Giovanna D'Amico, PhD

Blood (2010) 116 (21): 2306.

https://doi.org/10.1182/blood.V116.21.2306.2306

Published: 2010

Journal Articles

The HDAC INHIBITOR ITF2357 MODULATES KEY HEMATOPOIETIC GENES in JAK2 V617F CELLS From MYELOPROLIFERATIVE Neoplasm PATIENTS

Ariel Amaru, MD, Katia Todoerti, PhD, Anna Pellicioli, Luca Donadoni, Giacomo Tuana, Olga Pedrini, Guido Finazzi, MD, Antonino Neri, MD, Gianluca Fossati, Alessandro Rambaldi, MD, Martino Introna, MD, Luigia Lombardi, Josée Golay, PhD

Blood (2010) 116 (21): 797.

https://doi.org/10.1182/blood.V116.21.797.797

Published: 2010

Journal Articles

Enhanced Killing of Human B Lymphoma Targets by Combined Use of Cytokine Induced Killer (CIK) Cultures and Anti-CD20 Antibodies

Alice Pievani, PhD, Camilla Belussi, Christian Klein, PhD, Alessandro Rambaldi, MD, Josée Golay, Martino Introna, MD

Blood (2010) 116 (21): 4285.

https://doi.org/10.1182/blood.V116.21.4285.4285

Published: 2010

Journal Articles

A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results.

Monica Galli, MD, PhD, Silvia Salmoiraghi, PhD, Josée Golay, PhD, Antonella Gozzini, MD, Alberto Bosi, MD, Claudia Crippa, MD, Giuseppe Rossi, MD, Norbert Pescosta, MD, Sergio Cortelazzo, MD, Alessandra Sechi, PhD, Tiziano Oldoni, MD, Alessandro Rambaldi, MD

Blood (2007) 110 (11): 1175.

https://doi.org/10.1182/blood.V110.11.1175.1175

Published: 2007

Journal Articles

Selective Targeting of the JAK2 V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.

Vittoria Guerini, PhD, Valentina Barbui, PhD, Orietta Spinelli, PhD, Anna Salvi, Chiara Dellacasa, MD, Martino Introna, MD, Tiziano Barbui, MD, Josée Golay, PhD, Alessandro Rambaldi, MD

Blood (2007) 110 (11): 555.

https://doi.org/10.1182/blood.V110.11.555.555

Published: 2007

Journal Articles

Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.

David Daydé, Florence Dommange, Stéphanie Lerondel, Josée Golay, Alain Le Pape, Gilles Paintaud, Pierre Bardos, Hervé Watier, Guillaume Cartron

Blood (2007) 110 (11): 1400.

https://doi.org/10.1182/blood.V110.11.1400.1400

Published: 2007

Journal Articles

From the bench to the bedside: ways to improve rituximab efficacy

Guillaume Cartron, Hervé Watier, Josée Golay, Philippe Solal-Celigny

Blood (2004) 104 (9): 2635–2642.

https://doi.org/10.1182/blood-2004-03-1110

Published: 2004

Journal Articles

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

Emer Bourke, Daniela Bosisio, Josée Golay, Nadia Polentarutti, Alberto Mantovani

Blood (2003) 102 (3): 956–963.

https://doi.org/10.1182/blood-2002-11-3355

Published: 2003

Journal Articles

Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3

Donatella Amico, Anna Maria Barbui, Eugenio Erba, Alessandro Rambaldi, Martino Introna, Josée Golay

Blood (2003) 101 (11): 4589–4597.

https://doi.org/10.1182/blood-2002-07-2311

Published: 2003

Journal Articles

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

Josée Golay, Manuela Lazzari, Valeria Facchinetti, Sergio Bernasconi, Gianmaria Borleri, Tiziano Barbui, Alessandro Rambaldi, Martino Introna

Blood (2001) 98 (12): 3383–3389.

https://doi.org/10.1182/blood.V98.12.3383

Published: 2001

Journal Articles

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

Josée Golay, Luisella Zaffaroni, Thomas Vaccari, Manuela Lazzari, Gian-Maria Borleri, Sergio Bernasconi, Francesco Tedesco, Alessandro Rambaldi, Martino Introna

Blood (2000) 95 (12): 3900–3908.

https://doi.org/10.1182/blood.V95.12.3900

Published: 2000

NARROW

Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients

A Phase II Study of Sequential Administration of DLI and Cytokine Induced Killer (CIK) Cells in Patients with Hematologic Malignancies Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation: Preliminary Results

Understanding the Immunomodulatory Effect of Mesenchymal Stem Cell Infused In Transplanted Patients with Steroid-Refractory GvHD

The HDAC INHIBITOR ITF2357 MODULATES KEY HEMATOPOIETIC GENES in JAK2 V617F CELLS From MYELOPROLIFERATIVE Neoplasm PATIENTS

Enhanced Killing of Human B Lymphoma Targets by Combined Use of Cytokine Induced Killer (CIK) Cultures and Anti-CD20 Antibodies

A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results.

Selective Targeting of the JAK2 V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.

Quantitative Bioluminescent Method Appropriate for Bimodality Analysis To Improve and Follow a Syngenic Murine Model of B-Cell Lymphoma Expressing Human CD20.

From the bench to the bedside: ways to improve rituximab efficacy

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only